Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: AIDS Behav. 2016 Mar;20(3):687–698. doi: 10.1007/s10461-015-1178-8

Table 1.

Socio-demographic and clinical characteristics of study participants

Characteristic N=1,474

n (%)
Age ≥50 years 512 (34.7)
Female 312 (21.2)
Race
 White 694 (47.1)
 Black 757 (51.4)
 Other/Unknown 23 (1.5)
Health Insurance
 Public 371 (25.2)
 Uninsured 517 (35.1)
 Private 586 (39.7)
CD4 ≥200 cells/μL 1305 (89.9)
Viral load ≥200 copies/mL 196 (13.4)
HIV transmission risk factor
 Injection drug use 123 (34.5)
 Heterosexual 594 (34.5)
 Men who have sex with men 832 (57.0)
Depressiona and/or Anxiety/Panicb
 Both 132 (9.0)
 Depressive symptoms only 94 (6.4)
 Anxiety/Panic only 171 (11.6)
 Unknown 97 (6.5)
 Neither 980 (66.5)
Substance use (excluding Marijuana)c
 Current 105 (7.1)
 Prior 413 (28.0)
 Never 869 (59.0)
 Unknown 87 (5.9)
Alcohol used
 At risk 175 (11.9)
 Unknown 92 (6.2)
 No/Low/ 1207 (81.9)
Paine
 Yes (moderate/severe) 618 (41.9)
 Unknown 67 (4.6)
 No 789 (53.5)

UAB=University of Alabama at Birmingham, Birmingham, AL, USA.

Missing data: Race (n=11), CD4 (n=22), Viral load (n=12), HIV transmission (n=15).

a

Patient Health Questionnaire-9 instrument (PHQ-9): score ≥10.

b

Patient Health Questionnaire-5 for Anxiety (PHQ-A) instrument.

c

Alcohol, Smoking, Substance Involvement Screening Test (ASSIST).

d

Alcohol Use Disorders Identification Test (AUDIT-C).

e

EUROQOL health related quality of life instrument.